Table 1:
Age, Gender, Therapy Duration and Blood Ferritin Levels in Groups Under Study
BTM
SCD
Control Group
Age (years)
31,09±6,54
27,75±5,49
27,57±5,06
Male/Female
14/9
15/5
20/10
DFX treatment duration (years)
12,48±2,83
11,9±2,25
-
Ferritin levels (ng/mL)
2036,17±2520,30
1988,95±2974,15
194,1±78,6